1
|
Schlösser M, Kartashev VV, Mikkola VH, Shemshura A, Saukhat S, Kolpakov D, Suladze A, Tverdokhlebova T, Hutt K, Heger E, Knops E, Böhm M, Di Cristanziano V, Kaiser R, Sönnerborg A, Zazzi M, Bobkova M, Sierra S. HIV-1 Sub-Subtype A6: Settings for Normalised Identification and Molecular Epidemiology in the Southern Federal District, Russia. Viruses 2020; 12:v12040475. [PMID: 32331438 PMCID: PMC7232409 DOI: 10.3390/v12040475] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/20/2020] [Revised: 04/16/2020] [Accepted: 04/17/2020] [Indexed: 01/08/2023] Open
Abstract
Russia has one of the largest and fastest growing HIV epidemics. However, epidemiological data are scarce. Sub-subtype A6 is most prevalent in Russia but its identification is challenging. We analysed protease/reverse transcriptase-, integrase-sequences, and epidemiological data from 303 patients to develop a methodology for the systematisation of A6 identification and to describe the HIV epidemiology in the Russian Southern Federal District. Drug consumption (32.0%) and heterosexual contact (27.1%) were the major reported transmission risks. This study successfully established the settings for systematic identification of A6 samples. Low frequency of subtype B (3.3%) and large prevalence of sub-subtype A6 (69.6%) and subtype G (23.4%) were detected. Transmitted PI- (8.8%) and NRTI-resistance (6.4%) were detected in therapy-naive patients. In therapy-experienced patients, 17.3% of the isolates showed resistance to PIs, 50.0% to NRTI, 39.2% to NNRTIs, and 9.5% to INSTIs. Multiresistance was identified in 52 isolates, 40 corresponding to two-class resistance and seven to three-class resistance. Two resistance-associated-mutations significantly associated to sub-subtype A6 samples: A62VRT and G190SRT. This study establishes the conditions for a systematic annotation of sub-subtype A6 to normalise epidemiological studies. Accurate knowledge on South Russian epidemiology will allow for the development of efficient regional frameworks for HIV-1 infection management.
Collapse
Affiliation(s)
- Madita Schlösser
- Institute of Virology, Faculty of Medicine and University Hospital of Cologne, University of Cologne, 50935 Cologne, Germany; (M.S.); (V.H.M.); (K.H.); (E.H.); (E.K.); (M.B.); (V.D.C.); (R.K.)
| | - Vladimir V. Kartashev
- Russian Southern Federal Center for HIV Control, 344000 Rostov-na-Donu, Russia; (V.V.K.); (D.K.); (A.S.); (T.T.)
- Department of Infectious Diseases, Rostov State Medical University, 344022 Rostov-na-Donu, Russia;
- Martsinovsky Institute of Medical Parasitology, Tropical and Vector Borne Diseases, Sechenov First Moscow State Medical University, 119435 Moscow, Russia
| | - Visa H. Mikkola
- Institute of Virology, Faculty of Medicine and University Hospital of Cologne, University of Cologne, 50935 Cologne, Germany; (M.S.); (V.H.M.); (K.H.); (E.H.); (E.K.); (M.B.); (V.D.C.); (R.K.)
| | - Andrey Shemshura
- Clinical Center of HIV/AIDS of the Ministry of Health of Krasnodar Region, 350015 Krasnodar, Russia;
| | - Sergey Saukhat
- Department of Infectious Diseases, Rostov State Medical University, 344022 Rostov-na-Donu, Russia;
| | - Dmitriy Kolpakov
- Russian Southern Federal Center for HIV Control, 344000 Rostov-na-Donu, Russia; (V.V.K.); (D.K.); (A.S.); (T.T.)
| | - Alexandr Suladze
- Russian Southern Federal Center for HIV Control, 344000 Rostov-na-Donu, Russia; (V.V.K.); (D.K.); (A.S.); (T.T.)
| | - Tatiana Tverdokhlebova
- Russian Southern Federal Center for HIV Control, 344000 Rostov-na-Donu, Russia; (V.V.K.); (D.K.); (A.S.); (T.T.)
| | - Katharina Hutt
- Institute of Virology, Faculty of Medicine and University Hospital of Cologne, University of Cologne, 50935 Cologne, Germany; (M.S.); (V.H.M.); (K.H.); (E.H.); (E.K.); (M.B.); (V.D.C.); (R.K.)
| | - Eva Heger
- Institute of Virology, Faculty of Medicine and University Hospital of Cologne, University of Cologne, 50935 Cologne, Germany; (M.S.); (V.H.M.); (K.H.); (E.H.); (E.K.); (M.B.); (V.D.C.); (R.K.)
| | - Elena Knops
- Institute of Virology, Faculty of Medicine and University Hospital of Cologne, University of Cologne, 50935 Cologne, Germany; (M.S.); (V.H.M.); (K.H.); (E.H.); (E.K.); (M.B.); (V.D.C.); (R.K.)
| | - Michael Böhm
- Institute of Virology, Faculty of Medicine and University Hospital of Cologne, University of Cologne, 50935 Cologne, Germany; (M.S.); (V.H.M.); (K.H.); (E.H.); (E.K.); (M.B.); (V.D.C.); (R.K.)
| | - Veronica Di Cristanziano
- Institute of Virology, Faculty of Medicine and University Hospital of Cologne, University of Cologne, 50935 Cologne, Germany; (M.S.); (V.H.M.); (K.H.); (E.H.); (E.K.); (M.B.); (V.D.C.); (R.K.)
| | - Rolf Kaiser
- Institute of Virology, Faculty of Medicine and University Hospital of Cologne, University of Cologne, 50935 Cologne, Germany; (M.S.); (V.H.M.); (K.H.); (E.H.); (E.K.); (M.B.); (V.D.C.); (R.K.)
| | - Anders Sönnerborg
- Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, 17177 Stockholm, Sweden;
| | - Maurizio Zazzi
- Department of Medical Biotechnology, University of Siena, 53100 Siena, Italy;
| | - Marina Bobkova
- Department of General Virology, Gamaleya Research Center of Epidemiology and Microbiology, 123098 Moscow, Russia;
| | - Saleta Sierra
- Institute of Virology, Faculty of Medicine and University Hospital of Cologne, University of Cologne, 50935 Cologne, Germany; (M.S.); (V.H.M.); (K.H.); (E.H.); (E.K.); (M.B.); (V.D.C.); (R.K.)
- Correspondence: ; Tel.: +49-221-4788-5807
| |
Collapse
|